Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis.

Bourget P, Amin A, Chandesris MO, Vidal F, Merlette C, Hirsch I, Cabaret L, Carvalhosa A, Mogenet A, Frenzel L, Damaj G, Lortholary O, Hermine O.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jan 1;944:175-81. doi: 10.1016/j.jchromb.2013.11.003. Epub 2013 Nov 15.

PMID:
24316764
[PubMed - indexed for MEDLINE]
2.

Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the tyrosine kinase inhibitor pazopanib in human plasma.

Sparidans RW, Ahmed TT, Muilwijk EW, Welzen ME, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Sep 15;905:137-40. doi: 10.1016/j.jchromb.2012.08.004. Epub 2012 Aug 10.

PMID:
22917595
[PubMed - indexed for MEDLINE]
3.

Liquid chromatography-tandem mass spectrometric assay for the JAK2 inhibitor CYT387 in plasma.

Sparidans RW, Durmus S, Xu N, Schinkel AH, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 May 1;895-896:174-7. doi: 10.1016/j.jchromb.2012.03.021. Epub 2012 Mar 23.

PMID:
22476054
[PubMed - indexed for MEDLINE]
4.

Liquid chromatography-tandem mass spectrometric assay for the ALK inhibitor crizotinib in mouse plasma.

Sparidans RW, Tang SC, Nguyen LN, Schinkel AH, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Sep 15;905:150-4. doi: 10.1016/j.jchromb.2012.08.021. Epub 2012 Aug 21.

PMID:
22940474
[PubMed - indexed for MEDLINE]
5.

Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor vemurafenib in human and mouse plasma.

Sparidans RW, Durmus S, Schinkel AH, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Mar 15;889-890:144-7. doi: 10.1016/j.jchromb.2012.02.010. Epub 2012 Feb 15.

PMID:
22386128
[PubMed - indexed for MEDLINE]
6.

Liquid chromatography-tandem mass spectrometric assay for the VEGFR inhibitor cediranib and its primary human metabolite cediranib-N⁺-glucuronide in plasma.

Sparidans RW, Durmus S, Xu N, Schinkel AH, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 May 1;895-896:169-73. doi: 10.1016/j.jchromb.2012.03.020. Epub 2012 Mar 23.

PMID:
22476055
[PubMed - indexed for MEDLINE]
7.

Liquid chromatography-tandem mass spectrometric assay for the PARP-1 inhibitor olaparib in combination with the nitrogen mustard melphalan in human plasma.

Sparidans RW, Martens I, Valkenburg-van Iersel LB, den Hartigh J, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jul 1;879(21):1851-6. doi: 10.1016/j.jchromb.2011.05.003. Epub 2011 May 7.

PMID:
21622034
[PubMed - indexed for MEDLINE]
8.

Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma.

Sparidans RW, Iusuf D, Schinkel AH, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 15;877(32):4090-6. doi: 10.1016/j.jchromb.2009.10.024. Epub 2009 Oct 30.

PMID:
19910267
[PubMed - indexed for MEDLINE]
9.

Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates.

Sparidans RW, Iusuf D, Schinkel AH, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 15;878(28):2751-9. doi: 10.1016/j.jchromb.2010.08.015. Epub 2010 Aug 21.

PMID:
20829130
[PubMed - indexed for MEDLINE]
10.

Liquid chromatography-tandem mass spectrometry assay for the EGFR inhibitor pelitinib in plasma.

Luethi D, Durmus S, Schinkel AH, Schellens JH, Beijnen JH, Sparidans RW.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 1;934:22-5. doi: 10.1016/j.jchromb.2013.06.030. Epub 2013 Jul 4.

PMID:
23892825
[PubMed - indexed for MEDLINE]
11.

Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor dabrafenib in mouse plasma.

Sparidans RW, Durmus S, Schinkel AH, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Apr 15;925:124-8. doi: 10.1016/j.jchromb.2013.02.025. Epub 2013 Feb 27.

PMID:
23537694
[PubMed - indexed for MEDLINE]
12.

Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry.

Ter Heine R, Rosing H, van Gorp EC, Mulder JW, Beijnen JH, Huitema AD.

J Pharm Biomed Anal. 2009 Feb 20;49(2):393-400. doi: 10.1016/j.jpba.2008.10.040. Epub 2008 Nov 5.

PMID:
19059744
[PubMed - indexed for MEDLINE]
13.

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.

Haouala A, Zanolari B, Rochat B, Montemurro M, Zaman K, Duchosal MA, Ris HB, Leyvraz S, Widmer N, Decosterd LA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jul 15;877(22):1982-96. doi: 10.1016/j.jchromb.2009.04.045. Epub 2009 May 13.

PMID:
19505856
[PubMed - indexed for MEDLINE]
14.

Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasma.

Sparidans RW, Durmus S, Schinkel AH, Schellens JH, Beijnen JH.

J Pharm Biomed Anal. 2014 Jan;88:626-9. doi: 10.1016/j.jpba.2013.10.016. Epub 2013 Oct 23.

PMID:
24216281
[PubMed - indexed for MEDLINE]
15.

Easy and fast LC-MS/MS determination of lidocaine and MEGX in plasma for therapeutic drug monitoring in neonates with seizures.

ter Weijden E, van den Broek MP, Ververs FF.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jan 15;881-882:111-4. doi: 10.1016/j.jchromb.2011.11.030. Epub 2011 Nov 30.

PMID:
22192875
[PubMed - indexed for MEDLINE]
16.

Liquid chromatography-tandem mass spectrometric assay for the cyclin-dependent kinase inhibitor AT7519 in mouse plasma.

Dolman ME, den Hartog IJ, Molenaar JJ, Schellens JH, Beijnen JH, Sparidans RW.

J Pharm Biomed Anal. 2014 Jan;88:216-20. doi: 10.1016/j.jpba.2013.08.051. Epub 2013 Sep 12.

PMID:
24080524
[PubMed - indexed for MEDLINE]
17.

Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring.

Matar KM.

J Pharm Biomed Anal. 2008 Nov 4;48(3):822-8. doi: 10.1016/j.jpba.2008.05.035. Epub 2008 Jun 3.

PMID:
18603399
[PubMed - indexed for MEDLINE]
18.

Liquid chromatography/tandem mass spectrometry method for the quantification of deserpidine in human plasma: Application to a pharmacokinetic study.

Zhang H, Zhong D, Zhang Z, Dai X, Chen X.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 1;877(27):3221-5. doi: 10.1016/j.jchromb.2009.06.005. Epub 2009 Jun 10.

PMID:
19620026
[PubMed - indexed for MEDLINE]
19.

Liquid chromatography-tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device.

Wiesen MH, Farowski F, Feldkötter M, Hoppe B, Müller C.

J Chromatogr A. 2012 Jun 8;1241:52-9. doi: 10.1016/j.chroma.2012.04.008. Epub 2012 Apr 11.

PMID:
22552204
[PubMed - indexed for MEDLINE]
20.

Liquid chromatography-tandem mass spectrometric assay for the nucleoside reverse transcriptase inhibitor emtricitabine in human plasma.

Sparidans RW, Prins JM, Schellens JH, Beijnen JH.

Biomed Chromatogr. 2007 Jun;21(6):621-7.

PMID:
17340566
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk